TGFB1 and type 1 diabetes mellitus: Despite differences in the process and the targeted diseases (EAE and type 1 diabetes), this latter approach described similar mechanisms to our therapy, including: apoptotic cell phagocytosis, TGF-β-dependent Treg generation [29].